Welcome to LookChem.com Sign In|Join Free
  • or
N-(2-PIPERIDIN-4-YL-ETHYL)-ACETAMIDE is a chemical compound with the molecular formula C10H18N2O. It is a derivative of the compound acetamide, with the addition of a piperidine group. This molecule is commonly used in pharmaceutical research and is considered to have potential therapeutic properties. The piperidine group is known for its bioactivity in various drugs and compounds, making N-(2-piperidin-4-yl-ethyl)-acetamide an interesting molecule for further study.
Used in Pharmaceutical Research:
N-(2-PIPERIDIN-4-YL-ETHYL)-ACETAMIDE is used as a research compound for its potential therapeutic properties. The addition of the piperidine group to the acetamide structure contributes to its bioactivity, making it a promising candidate for the development of new drugs and pharmaceuticals.
Used in Chemical Industry:
In the chemical industry, N-(2-PIPERIDIN-4-YL-ETHYL)-ACETAMIDE is used as a building block for the synthesis of more complex molecules with potential applications in various fields. Its unique structure and properties make it a valuable component in the creation of new chemical entities.

70922-35-9

Post Buying Request

70922-35-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

70922-35-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 70922-35-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,9,2 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 70922-35:
(7*7)+(6*0)+(5*9)+(4*2)+(3*2)+(2*3)+(1*5)=119
119 % 10 = 9
So 70922-35-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H18N2O/c1-8(12)11-7-4-9-2-5-10-6-3-9/h9-10H,2-7H2,1H3,(H,11,12)

70922-35-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(2-PIPERIDIN-4-YL-ETHYL)-ACETAMIDE

1.2 Other means of identification

Product number -
Other names 4-(2-[acetylamino]-ethyl)-piperidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:70922-35-9 SDS

70922-35-9Downstream Products

70922-35-9Relevant academic research and scientific papers

Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency

Brundish, Derek,Bull, Alice,Donovan, Vera,Fullerton, Joseph D.,Garman, Sheila M.,Hayler, Judy F.,Janus, Diana,Kane, Peter D.,McDonnell, Mark,Smith, Garrick P.,Wakeford, Robert,Walker, Clive V.,Howarth, Graham,Hoyle, William,Allen, Mark C.,Ambler, John,Butler, Keith,Talbot, Mark D.

, p. 4584 - 4603 (2007/10/03)

Mitsubishi's MD-805, a potent and selective inhibitor of thrombin which contains four stereogenic centers, has been the starting point for an optimization program. A systematic synthetic study resulted in thrombin inhibitors achiral at P2 and P3 but with

Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines

-

, (2008/06/13)

1-(3- or 4-substituted piperidino)phthalazines of the formula wherein R is C1-6 alkyl; Y is a 3- or 4-position substituent and is -X-(CHR1)m-Z wherein R1 is hydrogen or C1-6 alkyl; m is 1 or 2; X is oxygen or a direct link provided that when m is 1, X is a direct link; and Z is -N(R2)COR3, -N(R2)COOR3, -N(R2)SO2R3, -N(R2)SO2NR4R5, -N(R2)SOR3, -N(R2)CONR4R5 or -OCONR4R5, wherein R2 and R5 are each independently hydrogen or C1-6 alkyl; R3 is C1-6 alkyl, phenethyl, benzyl, C3-7 cycloalkyl, phenyl or pyridyl; R4 is hydrogen or R3; provided that when X is a direct link, R3 or R4 is C3-7 cycloalkyl; the pharmaceutically acceptable acid addition salts thereof; processes for their preparation; and their use as cardiac stimulants and phosphodiesterase inhibitors

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 70922-35-9